A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 38/57 (2006.01) A61K 39/40 (2006.01)
Patent
CA 2136953
A method for prophylactically or therapeutically treating sepsis or septic shock is described, wherein an inhibitor to tissue factor is administered to septic patients. Additionally, a method for treating inflammation is described wherein the inhibitor is administered to patients. This inhibitor is termed lipoprotein associated coagulation inhibitor, or commonly LACI. It is 38 kD and has 276 amino acids. LACI has now been shown to be useful for the treatment of sepsis, septic shock and inflammation.
Borden Ladner Gervais Llp
Cetus Oncology Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
A method for using lipoprotein associated coagulation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A method for using lipoprotein associated coagulation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method for using lipoprotein associated coagulation... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1377708